SCHEMBL2857199

SCHEMBL2857199

C/C=C(/C(=O)O)c1ccccc1Oc1cccc(Oc2ncccn2)c1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.49
KMT2A Q03164 5/20 0.49
KDM4E B2RXH2 1/20 0.45
POLB P06746 1/20 0.45
HTT P42858 2/20 0.44
MAPT P10636 2/20 0.44
GAA P10253 2/20 0.44
MAPK1 P28482 2/20 0.42
PKM P14618 1/20 0.42
CTNNB1 P35222 1/20 0.41
MTNR1B P49286 1/20 0.41
TLR4 O00206 1/20 0.39
TLR2 O60603 1/20 0.39
TSHR P16473 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
ALDH1A1 P00352 2/20 0.38
HSD17B10 Q99714 1/20 0.38
RAB9A P51151 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29359352 0.89 MEN1 (0.46) MEN1KMT2AKDM4EPOLBHTT
SCHEMBL2857195 0.89 MEN1 (0.46) MEN1KMT2AKDM4EPOLBHTT
SCHEMBL2857201 0.89 MEN1 (0.46) MEN1KMT2AKDM4EPOLBHTT
SCHEMBL2856609 0.89 KDM4E (0.40) MEN1KMT2AKDM4EPOLBHTT
SCHEMBL2855939 0.87 KDM4E (0.59) MEN1KMT2AKDM4EPOLBHTT
SCHEMBL2107594 0.87 KDM4E (0.59) MEN1KMT2AKDM4EPOLBHTT
SCHEMBL17459765 0.85 NR1H2 (0.37) MEN1KMT2AKDM4EPOLBHTT
SCHEMBL2853896 0.84 TDP1 (0.44) MEN1KMT2AKDM4EPOLBHTT
SCHEMBL8335575 0.84 TDP1 (0.44) MEN1KMT2AKDM4EPOLBHTT
SCHEMBL2107699 0.84 LMNA (0.51) MEN1KMT2AKDM4EPOLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 287 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12043600-B2 Microbiocidal compounds SYNGENTA CROP PROTECTION AG (CH) 2024-07-23 US disclosed
US-12012399-B2 Microbiocidal quinoline dihydro-(thiazine)oxazine derivatives SYNGENTA PARTICIPATIONS AG (CH) 2024-06-18 US disclosed
US-11882834-B2 Microbiocidal thiazole derivatives SYNGENTA PARTICIPATIONS AG (CH) 2024-01-30 US disclosed
EP-4271185-A1 DELIVERY SYSTEM FOR PLANT PROTECTION Omya International AG (CH) 2023-11-08 EP disclosed
US-11744246-B2 Preparation of mammalian oocyte for fertilization via a soluble human PH20 hyaluronidase polypeptide SYNGENTA PARTICIPATIONS AG (CH) 2023-09-05 US disclosed
EP-3717479-B1 MICROBIOCIDAL THIAZOLE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2023-07-05 EP disclosed
EP-3941898-B1 FUNGICIDAL COMPOUNDS SYNGENTA CROP PROTECTION AG (CH) 2023-06-07 EP disclosed
EP-3244732-B1 USE OF SURFACE-REACTED CALCIUM CARBONATE AS CARRIER FOR AGROCHEMICAL COMPOUNDS OMYA INT AG (CH) 2023-05-03 EP disclosed
US-11629138-B2 Microbiocidal picolinamide derivatives SYNGENTA PARTICIPATIONS AG (CH) 2023-04-18 US disclosed
US-11629129-B2 Microbiocidal picolinamide derivatives SYNGENTA PARTICIPATIONS AG (CH) 2023-04-18 US disclosed
US-7001903-B2 Synergistic insecticidal mixtures BAYER AKTIENGESELLSCHAFT (DE) 2006-02-21 US disclosed
US-20050187215-A1 synergistic mixture of certain previously disclosed cyclic ketoenols and agonists or antagonists of nicotinic acetylcholine receptors BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2005-08-25 US disclosed
US-6893651-B1 Synergistic combination of cyclic ketoenol with agonists or antagonists of nicotinic acetylcholine receptors; protecting plants BAYER AKTIENGESELLSCHAFT (DE) 2005-05-17 US disclosed
US-6846777-B2 Synergistic biocidal composition THOR GMBH (DE) 2005-01-25 US disclosed
US-20040127520-A1 Synergistic insecticidal mixtures DOW AGROSCIENCES LLC 2004-07-01 US disclosed
US-6686387-B2 SPINOSYNS AND AGONISTS OR ANTAGONISTS OF NICOTINIC ACETYLCHOLINE RECEPTORS; PESTICIDES BAYER AKTIENGESELLSCHAFT (DE) 2004-02-03 US disclosed
US-20030199490-A1 Synergistic biocidal composition THOR GMBH (DE) 2003-10-23 US disclosed
US-20030092641-A1 Synergistic insecticidal mixtures DOW AGROSCIENCES LLC 2003-05-15 US disclosed
US-6444667-B1 OF SPINOSYNS AND AGONISTS OR ANTAGONISTS OF NICOTINIC ACETYLCHOLINE RECEPTORS FOR PROTECTING PLANTS BAYER AKTIENGESELLSCHAFT (DE) 2002-09-03 US disclosed
US-5466693-A FOE USE IN THE CULTIVATION OF RICE IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1995-11-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030092641-A1 Synergistic insecticidal mixtures CHRM3, ACHE, CHRM2 MEN1 3394/4885KMT2A 2752/4885KDM4E 3852/4885
US-12043600-B2 Microbiocidal compounds MPO, MSR1, PRF1 MEN1 2194/4885KMT2A 3894/4885KDM4E 2462/4885
US-20040127520-A1 Synergistic insecticidal mixtures CHRM3, ACHE, CHRM2 MEN1 3394/4885KMT2A 2752/4885KDM4E 3852/4885
US-11882834-B2 Microbiocidal thiazole derivatives MSR1, TLR1, IFNG MEN1 2895/4885KMT2A 4259/4885KDM4E 3260/4885
US-12012399-B2 Microbiocidal quinoline dihydro-(thiazine)oxazine derivatives TLR1, TLR5, IDO1 MEN1 2306/4885KMT2A 3061/4885KDM4E 2885/4885
US-20050187215-A1 synergistic mixture of certain previously disclosed cyclic ketoenols and agonists or antagonists of nicotinic acetylcholine receptors CHRNG, CHRM3, CHRNE MEN1 4468/4885KMT2A 1952/4885KDM4E 1928/4885
US-11629138-B2 Microbiocidal picolinamide derivatives PRF1, CASP1, FPR1 MEN1 3561/4885KMT2A 4113/4885KDM4E 2969/4885
US-11744246-B2 Preparation of mammalian oocyte for fertilization via a soluble human PH20 hyaluronidase polypeptide PHF20, FUCA1, ZP1 MEN1 502/4885KMT2A 2043/4885KDM4E 4050/4885
US-11629129-B2 Microbiocidal picolinamide derivatives PRF1, CASP1, MSR1 MEN1 3568/4885KMT2A 4122/4885KDM4E 3192/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.